Gyógyszerészet 2017. november

Gyogyszereszet 1711 B1

{tab Távoktatás tesztkitöltés}

{ BreezingForms : MGYTavoktatas_2017_november }

{tab Tartalom}

[accordion width=”440″]

[item title=”Dr. Szász György emeritus professzor 90 éves – GYOGAI. 61.643-644 2017.”]

[/item]

[item title=”Hatvanéves a Szegedi Gyógyszerésztudományi Kar – A Szegedi Gyógyszerésztudományi Kar jubileumi ünnepsége  – GYOGAI. 61. 645-658. 2017.”]

[/item]

[/accordion]

Továbbképző közlemények

[accordion width=”440″]

[item title=”Csóka Ildikó: Az oktatás minőségbiztosítási aspektusai II. rész – GYOGAI. 61.659-664 2017.”]

Csóka, I.: Quality aspects of education Part II.

Extensive developments in medical and health technologies, paralelly with the changes in the structure of health care systems; induced a paradigm change in higher education as well.

This paradigm change can be summarized as follows: student-centred methodology, involvement of evidence based practices, enlarged course content on the whole treatment line (health promotion, prevention, treatment, rehabilitation); multi-, and interdisciplinarity in health care team, including pharmacists as well.

Therefore the whole course content and the learning outcomes of Hungarian pharmacy education went through a comprehensive development in order to educate pharmacists to become useful members of the health care team to fulfill an enlarged role for the society.

[/item]

[item title=”Budai Kinga Anna: Gyermekkori allergiák  – GYOGAI. 61. 588-597. 2017.”]

1. Tulassay, T.: Klinikai gyermekgyógyászat. Novák, Z. (fejezetszerk.): Allergiás betegségek. Medicina, Budapest 2016, 277-288 old.

2. Kadocsa, E.: Gyermekorvos Továbbképzés 13(2), 49-54 (2014)

3. Bousquet J, Van Cauwenberge P, Khaltaev N (ARIA Workshop Group; World Health Organiza-tion): J Allergy Clin Immunol 108(5 suppl): S147–S334 (2001).

4. Roberts, G., Xatzipsalti, M., Borrego L. M., Custovic A., Halken S., Hellings P. W., Papadopoulos N. G., Rotiroti G., Scadding G., Timmermans F., Valovirta E.: Allergy 68: 1102–1116. (2013)

5. Mezei Gy.: Gyermekorvos Továbbképzés 13(2), 55-59 (2014).

6. Brożek, J.L., Bousquet, J., Agache, I., Agarwal, A., Bachert, C., Bosnic-Anticevich, S., Brignardello-Petersen, R., Canonica, G.W., Casale, T., Chavannes, N.H., Correia de Sousa, J., Cruz, A.A., Cuello-Garcia, C.A., Demoly, P., Dykewicz, M., Etxeandia-Ikobaltzeta, I., Florez, I.D., Fokkens, W., Fonseca, J., Hellings, P.W., Klimek, L., Kowalski, S., Kuna, P., Laisaar, K.T., Larenas-Linnemann, D.E., Lødrup Carlsen, K.C., Manning, P.J., Meltzer, E., Mullol, J., Muraro, A., O’Hehir, R., Ohta, K., Panzner, P., Papadopoulos, N., Park, H.S., Passalacqua, G., Pawankar, R., Price, D., Riva, J.J., Roldán, Y., Ryan, D., Sadeghirad, B., Samolinski, B., Schmid-Grendelmeier, P., Sheikh, A., Togias, A., Valero, A., Valiulis, A., Valovirta, E., Ventresca, M., Wallace, D., Waserman, S., Wickman, M., Wiercioch, W., Yepes-Nuñez, J.J., Zhang, L., Zhang, Y., Zidarn, M., Zuberbier, T., Schünemann, H.J.: J Allergy Clin Immunol. 140(4), 950-958 (2017).

7. Santos, A.F., Borrego, L.M., Rotiroti, G., Scadding, G., Roberts G.: Clin Transl Allergy. 5(1), 2 (2015).

8. Brozek, J.L., Bousquet, J., Baena-Cagnani, C.E., Bonini, S., Canonica, G.W., Casale, T.B., van Wijk, R.G., Ohta, K., Zuberbier, T., Schünemann, H.J.: J Allergy Clin Immunol. 126(3), 466-76 (2010).

9. Bousquet, J., Van Cauwenberge, P., Khaltaev, N.: Allergy. 59(4), 373-87 (2004).

10. http://emedicine.medscape.com/article/889259-overview (2017.10.15.) Medscape: Pediatric Allergic Rhinitis.

11. http://www.medimagister.hu/data/upload/File/docstore/20092/gy-gyermekkoriasthma.pdf (2017.10.18.)

12. Szefler, S. J., Chmiel, J. F., Fitzpatrick, A. M., Giacoia, G., Green, T. P., Jackson, D. J., Nielsen, H. C., Phipatanakul, W., Raissy, H. H.: J Allergy Clin Immunol. 133(1):3-13 (2014)

13. Gina Committees: Pocket Guide for Asthma Management and Prevention (For Adults and Children older than 5 years). Global initiative for asthma. Pocket guide for professionals, updated 2017.

14. Gina Committees: Pocket Guide for Asthma Management and Prevention in Children 5 Years and Younger. Global initiative for asthma. Pocket guide for professionals, updated 2015.

15. Ronina, A., Covar1, Fuhlbrigge, A.F., Williams, P., Kelly, H.W. and the Childhood Asthma Management Program Research Group: Curr Respir Care Rep. 1(4), 243–250 (2012).

16. Lyons, J.J., Milner, J.D., Stone, K.D.: Immunol Allergy Clin North Am. 35(1), 161–183 (2015).

17. Kovács E.: Gyógyszerészet 61. 598-602. (2017)

18. Soós Gy.: Gyógyszerészet 61, 522-526 (2017).

19. Kliegman, R. M.: Nelson Textbook of Pediatrics 20th Edition. Nowak-Wegrzyn, A., Sampson, H. A., Sicherer, S. H. Food Allergy and Adverse Reactions to Foods. 1573-1580 (2016)

20. Hidvégi E.: Gyermekorvos Továbbképzés 13(2), 60-63 (2014)

21. https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Food-Allergy-Summary.pdf (2017.10.19.)

Budai, K. A.: Paediatric allergies

The prevalence of paediatric allergy is increasing, which includes the allergic rhinitis, asthma, atopic dermatitis, food allergy, drug allergy, insect bite and anaphylaxis. The comorbidity of these diseases occurs quite often.

The allergic rhinitis (AR) appears most frequently at school age. Because of the risk factor of the later emerging asthma, therefore in certain cases it is also necessary to investigate. The therapy begins with oral or local second-generation antihistamines or with local chromones. In mild persistent or in moderate-severe intermittent rhinitis the intranasal corticosteroids are the most effective.

The asthma develops typically in early childhood, but the symptoms can disappear in adolescents. For children under the age of 5, both the diagnosis and the drug therapy are challenging. The management of asthma comprises the decrease of environmental allergens and trigger factors, the drug therapy and the immunotherapy, as well. The treatment is stepwise, the short-acting β2-agonists (salbutamol) are the first choice as reliever drugs, and the inhaled corticosteroids are used as early controllers.

Food allergy may occur in infants. The most frequently allergens are the milk proteins, egg, soy, peanut, nuts, fish, shellfish. In the prevention the exclusive breastfeeding until the age of 4-6 months is of impact and after that the high-risk foods can be introduced. The basis of the therapy is the elimination of allergenic food, but the broad exclusionary, highly restrictive diet is not necessary. Anaphylaxis should be treated with adrenaline.

[/item]

[/accordion]

Aktuális oldalak

[accordion width=”440″]

[item title=”Bozó Tamás: Kémiai Nobel-díj a krio-elektronmikroszkópia kifejlesztéséért – GYOGAI 61. 676-678. 2017.”]

Bozó, T.: Nobel prize ñ chemistry 2017

[/item]

[/accordion]

Hírek

Magyar Kálmán (1933-2017) – Beszámoló a 7th BBBB konferenciáról – Gyógyszerkémiai és Gyógyszertechnológiai Szimpózium ’17 – A II. Hargita megyei Gyógyszerész Napok eseményei – Őszi találkozó a Pálfája Oktatóközpontban – Hírek Szegedről – Somogyi Orsolya Ph.D. védése

Tallózó

{tab Távoktatási cikkek}

Csóka Ildikó: Az oktatás minőségbiztosítási aspektusai II. rész

Budai Kinga Anna: Gyermekkori allergiák

{/tabs}